DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 9,000,041 B2 Dasseux Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 9,000,041 B2 Dasseux Et Al USOO9000041B2 (12) United States Patent (10) Patent No.: US 9,000,041 B2 Dasseux et al. (45) Date of Patent: Apr. 7, 2015 (54) HYDROXYL COMPOUNDS AND (52) U.S. Cl. COMPOSITIONS FOR CHOLESTEROL CPC ............... C07C 59/245 (2013.01); C07C31/20 MANAGEMENT AND RELATED USES (2013.01); C07C31/22 (2013.01); C07C3I/24 (2013.01); C07C 59/11 (2013.01); C07C (71) Applicants: Jean-Louis Henri Dasseux, Toulouse 59/285 (2013.01); C07C 59/29 (2013.01); Toulouse (FR) C07C 59/54 (2013.01); C07C 62/02 (2013.01); C07C 62/06 (2013.01); C07C 65/17 (2013.01); (72) Inventors: Jean-Louis Henri Dasseux, Toulouse C07C 69/757 (2013.01); C07D 213/80 (FR): Carmen Daniela Oniciu, (2013.01); C07D 309/10 (2013.01); C07D Toulouse (FR) 309/12 (2013.01); C07D405/12 (2013.01); C07F 9/093 (2013.01); C07F 9/094 (2013.01); (73) Assignee: Esperion Therapeutics, Inc., Ann C07F 9/117 (2013.01); C07F 9/2425 Arbor, MI (US) (2013.01); C07F 9/4423 (2013.01); C07C 2101/02 (2013.01); C07C 2101/04 (2013.01); (*) Notice: Subject to any disclaimer, the term of this C07C 2101/08 (2013.01) patent is extended or adjusted under 35 (58) Field of Classification Search U.S.C. 154(b) by 0 days. NoneSee application file for complete search history. (21) Appl. No.: 13/925,818 (56) References Cited (22) Filed: Jun. 24, 2013 U.S. PATENT DOCUMENTS (65) Prior Publication Data S.E.I k A 1919: E.C. C. a. al. US 2013/02891 17 A1 Oct. 31, 2013 (Continued) Related U.S. Application Data FOREIGN PATENT DOCUMENTS (60) Continuation of application No. 13/470,825, filed on EP O 284 108 9, 1987 May 14, 2012, now Pat. No. 8,497.301, which is a FR 1545 224 A 11, 1968 continuation of application No. 12/870,184, filed on (Continued) Aug. 27, 2010, now abandoned, which is a division of OTHER PUBLICATIONS application No. 1 1/680,105, filed on Feb. 28, 2007, now Pat. No. 7,812,199, which is a division of Ackerley, et al., A Novel Approach to Dual-Acting Thromboxane application No. 10/743,470, filed on Dec. 23, 2003, Receptor Antagonist/Synthase Inhibitors Based on the link of 1.3- now Pat. No. 7,335,799. dioxane-thrombaxane receptor antagonists and -thromboxane (60) Provisional application No. 60/441,795, filed on Jan. synthase inhibitors, J. Med. Chem. 38:1608-1628 (1995). 23, 2003. (Continued) (51) Int. Cl. Primary Examiner — Sudhakar Katakam A6 IK3I/20 (2006.01) (74) Attorney, Agent, or Firm — Goodwin Procter LLP C07C 59/245 (2006.01) (57) ABSTRACT C07C3L/20 (2006.01) C07C3L/22 (2006.01) The present invention relates to novel hydroxyl compounds, C07C3L/24 (2006.01) compositions comprising hydroxyl compounds, and methods C07C 59/11 (2006.01) useful for treating and preventing a variety of diseases and C07C 59/285 (2006.01) conditions Such as, but not limited tO aging, Alzheimer's C07C 59/29 (2006.01) Disease, cancer, cardiovascular disease, diabetic nephropa CD7C 59/246 (2006.01) thy, diabetic retinopathy, a disorder of glucose metabolism, C07C 59/48 (2006.01) dyslipidemia, dyslipoproteinemia, hypertension, impotence, C07C 59/54 (2006.01) inflammation, insulin resistance, lipid elimination in bile, CD7C 62/02 (2006.01) obesity, oxysterol elimination 1. bile, pancreatitis, pancreat CD7C 62/06 (2006.01) t1uS, Parkinson's disease, a perox1some proliferator activated C07C 65/17 (2006.01) receptor-associated disorder, phospholipid elimination 1. C07C 69/757 (2006.01) bile, renal disease, septicemia, metabolic syndrome disorders CO7D 23/80 (2006.01) (e.g., Syndrome X), thrombotic disorder. Compounds and C07D 309/10 (2006.01) methods of the invention can also be used to modulate C C07D 309/12 (2006.01) reactive protein or enhance bile production in a patient. In CO7D 405/2 (2006.01) Certa1n embodiments, the compounds, compositions, and C07F 9/09 (2006.01) methods of the invention are useful in combination therapy C07F 9/11 7 (2006.01) with other therapeutics, Such as hypocholesterolemic and C07F 9/24 (2006.01) hypoglycemic agents. C07F 9/44 (2006.01) 27 Claims, No Drawings US 9,000,041 B2 Page 2 (56) References Cited FOREIGN PATENT DOCUMENTS U.S. PATENT DOCUMENTS GB 1196594 7, 1970 GB 1196595 7, 1970 3,773,946 A 1 1/1973 Creger GB 1196596 7, 1970 3,930,024. A 12/1975 Creger GB 1196597 7, 1970 4,287,200 A 9/1981 Kawamatsu et al. GB 1196598 7, 1970 4.584,321. A 4/1986 Manghisi et al. WO WO96,30328 10, 1996 4,613,593. A 9/1986 Yamatsu et al. WO WO 98.30530 A T 1998 4,634,719 A 1, 1987 Takaishi et al. WO WO99/OO116 1, 1999 4,639,344. A 1/1987 Bar-ran W8 wo.88 A .283 4,689,344 A 8, 1987 Bar-Tana 4,711,896 A 12/1987 Bar-Tana et al. OTHER PUBLICATIONS 4,714,762 A 12/1987 Hoefleet al. 5,166,174 A 11/1992 Ueno et al. Acton et al., 1996. “Identification of scavenger receptor SR-BI as a 5,225,439 A 7, 1993 Ueno et al. high density lipoprotein receptor'. Science. 271 (5248):518-20. 5,284,858 A 2f1994 Ueno et al. Ahrens et al., 1967. "A direct method for preparing pyridoxal and 5,380,709 A 1/1995 Ueno et al. 4-pyridoxic~ acid (1),s J. Haterocycl. Chem.4:625-26. 5,428,062 A 6, 1995 Ueno et al. Alexander, Ket al., 1948, '4,4'-Dichlorodibulylg&M Y ether and its deriva 5,504,073.5,502,198 A 4,3, 1996 HomanPicard et al. tiveslves Iromfrom tetrahydrofuran'.Ieuanyltouran. J. AmnemSoc.Am. Chem. Soc. 70:(U1839-44. 1839-42 5,578,639 A 11/1996 Homan Badimon et al., 1992. “Roless ofYi High density lipoproteins in the 5.633.287 A 5, 1997 Lee et al. regression of atherosclerosis'. Circulation 86 (Suppl):III86-94. 5.648387 A 7/1997 Bisgaier et al. Bailey, et al., 1990, Convenient general method for the preparation 5,750,569 A 5/1998 Bisgaier et al. of primary alkeyllithiums by lithium-iodine exchange'. J. Org. 5,756,344. A 5/1998 Onda et al. Chem, 55:54.04-06. 5.756,544. A 5/1998 Bisgaier et al. Barrans et al., 1996, "Pre-beta HDL; structure and metabolism', 5,783,600 A 7/1998 Bisgaier et al. Biochim. Biophys. Acta. 1300(2):73-85. 5,834,596 A 11/1998 Ageland et al. Becker et al., 1982, “Intramolecular photoaddition of terminal 5,886,034 A 3, 1999 Ueno et al. allenes to conjugated cyclohexenones”. J. Org. Chem.47:3297-3310. 5,968,963 A 10, 1999 Homan Beilstein Database, Beilstein Institute for Organic Chemistry, Frank 5,981,595 A 11/1999 Picard et al. furt-Main, Germany, Aug. 28, 1992, BRN 500 1278 and 5025574. 6,004,925 A 12/1999 Dasseux et al. Beilstein Database, Beilstein Institute for Organic Chemistry, Frank 6,017,905 A 1/2000 Roark et al. furt-Main, Germany, Feb. 12, 1993, BRN 5732477. 6,037,323 A 3/2000 Dasseux et al. Beilstein Database, Beilstein Institute for Organic Chemistry, Frank 6,093,719 A 7/2000 Bocan furt-Main, Germany, Nov. 12, 1996, BRN 7473.723. 6,093,744 A 7/2000 Lee et al. Beilstein Database, Beilstein Institute for Organic Chemistry, Frank 6,124.309 A 9, 2000 Bocan furt-Main, Germany, Feb. 27, 1989, BRN 1778991. 6,143,755 A 11/2000 Bocan Beilstein Database, Beilstein Institute for Organic Chemistry, Frank 6.410,802 B1 6/2002 Dasseux et al. furt-Main, Germany, Jul. 11, 1989, BRN 2961112. 6,459,003 B1 10/2002 Dasseux et al. Beilstein Database, Beilstein Institute for Organic Chemistry, Frank 6,506,799 B1 1/2003 Dasseux et al. furt-Main, Germany, Feb. 27, 1989, BRN 1741087. 6,646,170 B2 11/2003 Dasseux et al. Beilstein Database, Beilstein Institute for Organic Chemistry, Frank 6,673,780 B2 1/2004 Dasseux et al. furt-Main, Germany, May 4, 1993, BRN 5836264. 6,699.910 B2 3/2004 Dasseux et al. Beilstein Database, Beilstein Institute for Organic Chemistry, Frank 6,703,422 B2 3/2004 Dasseux et al. furt-Main, Germany, Feb. 27, 1989, BRN 1733552. 6,713,507 B2 3/2004 Dasseux et al. Beilstein Database, Beilstein Institute for Organic Chemistry, Frank 6,790,953 B2 9/2004 Dasseux et al. furt-Main, Germany, Feb. 27, 1989, BRN 1784568. 6,831,105 B2 12/2004 Dasseux et al. Beilstein Database, Beilstein Institute for organic Chemistry, Frank 6,909,014 B2 6/2005 Dasseux et al. furt-Main, Germany, Aug. 28, 1992, BRN 5021975. 7,119,221 B2 10/2006 Dasseux et al. Bernady et al., 1979. “Prostaglandins and congeners. 20...Sup. 1.2 7,192,940 B2 3/2007 Dasseux et al. Svnthesisynthesis of prostaglandinslandi via conjugate additiondditi off lithiumlithi mm 7,304,093 B2 12/2007 Dasseux et al. trans-1-alkenyltrialkylalanate reagents. A novel reagent for conju 7,335,689 B2 2/2008 Dasseux et al. gate 1,4-additions”.-- ? J. Org. Chem. 44:1438-47. 7,335,799 B2 2/2008 Dasseux et al. Bhanotel al., 1977. Synthetic Studies on Terpenoids.5. Synlheses of 7,405,226 B2 7/2008 Dasseux et al. gamma.- and delta.-Lactones from. beta.-(2,7-Dimelhyl-1 7,705,1777,576, 130 B2 4/20108, 2009 OniciuDasseux et et al. al. I2-dihydr ydroxycycloheplyl)propionic loheplv1 ionic Acid. J. Org. Chem.Ch 42:1623 7,838,5547,812,199 B2 11/201010/2010 Dasseux et al.
Load more

Recommended publications
  • Crystal Structure of Steroid Reductase SRD5A Reveals Conserved Steroid Reduction Mechanism
    ARTICLE https://doi.org/10.1038/s41467-020-20675-2 OPEN Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism Yufei Han 1,9, Qian Zhuang2,9, Bo Sun3,9, Wenping Lv 4,9, Sheng Wang5,9, Qingjie Xiao6, Bin Pang1, ✉ Youli Zhou1, Fuxing Wang1, Pengliang Chi6, Qisheng Wang3, Zhen Li7, Lizhe Zhu 4, Fuping Li8, Dong Deng6 , ✉ ✉ ✉ Ying-Chih Chiang 1 , Zhenfei Li 2 & Ruobing Ren 1 Steroid hormones are essential in stress response, immune system regulation, and repro- 1234567890():,; duction in mammals. Steroids with 3-oxo-Δ4 structure, such as testosterone or progesterone, are catalyzed by steroid 5α-reductases (SRD5As) to generate their corresponding 3-oxo-5α steroids, which are essential for multiple physiological and pathological processes. SRD5A2 is already a target of clinically relevant drugs. However, the detailed mechanism of SRD5A- mediated reduction remains elusive. Here we report the crystal structure of PbSRD5A from Proteobacteria bacterium, a homolog of both SRD5A1 and SRD5A2, in complex with the cofactor NADPH at 2.0 Å resolution. PbSRD5A exists as a monomer comprised of seven transmembrane segments (TMs). The TM1-4 enclose a hydrophobic substrate binding cavity, whereas TM5-7 coordinate cofactor NADPH through extensive hydrogen bonds network. Homology-based structural models of HsSRD5A1 and -2, together with biochemical char- acterization, define the substrate binding pocket of SRD5As, explain the properties of disease-related mutants and provide an important framework for further understanding of the mechanism of NADPH mediated steroids 3-oxo-Δ4 reduction. Based on these analyses, the design of therapeutic molecules targeting SRD5As with improved specificity and therapeutic efficacy would be possible.
    [Show full text]
  • Metabolomics Profiling Reveals New Aspects of Dolichol Biosynthesis in Plasmodium Falciparum
    bioRxiv preprint doi: https://doi.org/10.1101/698993; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Metabolomics profiling reveals new aspects of dolichol biosynthesis in Plasmodium falciparum Flavia M. Zimbres1,2#, Ana Lisa Valenciano1,2#, Emilio F. Merino1,2, Anat Florentin3,2, Nicole R. Holderman1, Guijuan He4, Katarzyna Gawarecka5, Karolina Skorupinska-Tudek5, Maria L. Fernández-Murga6, Ewa Swiezewska5, Xiaofeng Wang4, Vasant Muralidharan3,2, Maria Belen Cassera1,2* From the 1Department of Biochemistry & Molecular Biology, University of Georgia, Athens GA 30602; 2Center for Tropical and Emerging Global Diseases (CTEGD), University of Georgia, Athens GA 30602; 3Department of Cellular Biology, University of Georgia, Athens GA 30602; 4School of Plant and Environmental Sciences, Virginia Tech, Blacksburg VA 24061; 5Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5A, 02-106 Warsaw, Poland; 6Laboratory of Experimental Pathology, Health Research Institute Hospital La Fe, Valencia 46026, Spain # Contributed equally to this work * To whom correspondence should be addressed: Maria Belen Cassera: Department of Biochemistry & Molecular Biology and Center for Tropical and Emerging Global Diseases (CTEGD), University of Georgia, Athens GA 30602; [email protected]; Tel. (706) 542-5192. Keywords: Plasmodium, malaria, polyprenol, dolichol, polyprenol reductase, SRD5A3, LC-HRMS The cis-polyisoprenoid lipids namely polyprenols, dolichols and their derivatives are linear polymers of several isoprene units. In eukaryotes, polyprenols and dolichols are synthesized as a mixture of four or more homologues of different length with one or two predominant species with sizes varying among organisms.
    [Show full text]
  • TIBS-Revised Eichler and Imperiali-2017-Withfigs
    Stereochemical Divergence of Polyprenol Phosphate Glycosyltransferases The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Eichler, Jerry, and Barbara Imperiali. “Stereochemical Divergence of Polyprenol Phosphate Glycosyltransferases.” Trends in Biochemical Sciences 43, no. 1 (January 2018): 10–17. As Published https://doi.org/10.1016/j.tibs.2017.10.008 Publisher Elsevier Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/119846 Terms of Use Creative Commons Attribution-NonCommercial-NoDerivs License Detailed Terms http://creativecommons.org/licenses/by-nc-nd/4.0/ Stereochemical divergence of polyprenol phosphate glycosyltransferases Jerry Eichler1 and Barbara Imperiali2 1Dept. of Life Sciences, Ben Gurion University of the Negev, Beersheva, Israel 2Dept. of Biology and Dept. of Chemistry, Massachusetts Institute of Technology, Cambridge MA, USA *correspondence to: [email protected] (Jerry Eichler) or [email protected] (Barbara Imperiali) Keywords: Dolichol phosphate, dolichol phosphate glucose synthase, dolichol phosphate mannose synthase, polyprenol phosphate, protein glycosylation, stereochemistry 1 Abstract In the three domains of life, lipid-linked glycans contribute to various cellular processes, ranging from protein glycosylation to glycosylphosphatidylinositol anchor biosynthesis to peptidoglycan assembly. In generating many of these glycoconjugates, phosphorylated polyprenol-based lipids are charged with single sugars by polyprenol
    [Show full text]
  • Prenol Nomenclature Recommendations 1986
    Eur. J. Biochem. 167,181 -184 (1987) 0 FEBS 1987 EJB - 870270 IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN) Prenol nomenclature Recommendations 1986 CONTENTS The carbon atoms along the main chain are numbered Introduction ................................. 181 from C-1, the atom that carries the hydroxyl group (C-15.11 General terms ................................ 181 of ref. 8). The methyl group carried by atom C-3 contains Pr-1. Prenol. .............................. 181 atom C-3l, that carried by atom C-7 contains atom C-7l, etc. Pr-2. Polyprenol ........................... 181 Pr-3. Esters and their derivatives . 181 Note Pr-4. Number of residues ....... 181 Stereochemistry ................. 181 This use of superscript numbers is based on section TP-2.1 Pr-5. Double bonds. ............ 181 of the recommendations for the nomenclature of tetrapyrroles Pr-6. Order of stereochemical prefixes. ............ 182 [9]. In the printing of these recommendations in the European Pr-7. Multiplicative prefixes ................... 182 Journal of Biochemistry the relevant paragraph was acci- Spec fie compounds ............................. 182 dentally transposed to the caption of Table 2. Pr-8. Trivial names ......................... 182 The repeating CsHs unit (inside the brackets of structure Pr-9. Isopentenyl diphosphate .................. 184 Pr-10. Relationship between polyprenols and isoprenoids 184 Z) is termed an isoprene unit or an isoprene residue. Prenols Pr-1 1. Juvenile hormones ...................... 184 and their esters are precursors of a variety of compounds, Pr-12. Dolichols ............................ 184 including terpenes and steroids, that have much of the carbon References ............... .............. 184 skeleton intact. Such compounds are known as isoprenoids. INTRODUCTION Pr-2. Polyprenol. Polyprenols represent a subgroup of pre- nols. The term polyprenol, already widely used (e.
    [Show full text]
  • Androgen Signaling in Sertoli Cells Lavinia Vija
    Androgen Signaling in Sertoli Cells Lavinia Vija To cite this version: Lavinia Vija. Androgen Signaling in Sertoli Cells. Human health and pathology. Université Paris Sud - Paris XI, 2014. English. NNT : 2014PA11T031. tel-01079444 HAL Id: tel-01079444 https://tel.archives-ouvertes.fr/tel-01079444 Submitted on 2 Nov 2014 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITE PARIS-SUD ÉCOLE DOCTORALE : Signalisation et Réseaux Intégratifs en Biologie Laboratoire Récepteurs Stéroïdiens, Physiopathologie Endocrinienne et Métabolique Reproduction et Développement THÈSE DE DOCTORAT Soutenue le 09/07/2014 par Lavinia Magdalena VIJA SIGNALISATION ANDROGÉNIQUE DANS LES CELLULES DE SERTOLI Directeur de thèse : Jacques YOUNG Professeur (Université Paris Sud) Composition du jury : Président du jury : Michael SCHUMACHER DR1 (Université Paris Sud) Rapporteurs : Serge LUMBROSO Professeur (Université Montpellier I) Mohamed BENAHMED DR1 (INSERM U1065, Université Nice)) Examinateurs : Nathalie CHABBERT-BUFFET Professeur (Université Pierre et Marie Curie) Gabriel
    [Show full text]
  • Researchers Find Cause of Metabolic Disease -- and Possible Cure 15 July 2010
    Researchers find cause of metabolic disease -- and possible cure 15 July 2010 An international team of scientists, led by disorder, but also to solve a basic science problem." researchers at the University of California, San Diego School of Medicine, has discovered the After translation, many proteins are modified with gene mutation responsible for a condition in which the addition of glycans (polysaccharides or eye and brain development is severely disrupted in oligosaccharides) that are necessary to help them affected infants. perform their functions. This modification occurs in a specific cell compartment - the membrane of the They also suggest a potential remedy that would endoplasmic reticulum - where the glycans are involve a simple, daily dietary supplement. transported by a lipid before transferring onto proteins. The condition is one of the congenital disorders of glycosylation or CDG, a group of syndromes in Dolichol is the lipid carrier for glycans used during which inborn metabolic errors result in serious, protein glycosylation; its availability is critical to sometimes fatal, malfunctions of different organ accomplishing the modification process, but the systems, especially the nervous system, muscles synthesis or production of dolichol was poorly and intestines. Children and adults with CDG have understood, especially the last step when varying degrees of disability, including cognitive polyprenol, a natural long-chain alcohol, is reduced impairment and speech difficulties, poor motor to create dolichol. skills, vision problems and stroke-like episodes. CDG is rare, but for most of the disorders, there is "Dolichol is used by the cell like a truck to transport no treatment. glycans to their destination but also as a support to build them" said Vincent Cantagrel, a UC San Writing in the July 15 online edition of the journal Diego postdoctoral fellow and study co-author.
    [Show full text]
  • Plant Polyprenols Reduce Demyelination and Recover Impaired Oligodendrogenesis and Neurogenesis in the Cuprizone Murine Model of Multiple Sclerosis
    Received: 19 September 2018 Revised: 11 January 2019 Accepted: 9 February 2019 DOI: 10.1002/ptr.6327 RESEARCH ARTICLE Plant polyprenols reduce demyelination and recover impaired oligodendrogenesis and neurogenesis in the cuprizone murine model of multiple sclerosis Marina Y. Khodanovich1 | Anna O. Pishchelko1 | Valentina Y. Glazacheva1 | Edgar S. Pan1 | Elena P. Krutenkova1 | Vladimir B. Trusov2 | Vasily L. Yarnykh1,3 1 Laboratory of Neurobiology, Tomsk State University, Tomsk, Russian Federation Recent studies showed hepatoprotective, neuroprotective, and immunomodulatory 2 Prenolica Limited (formerly Solagran Limited), properties of polyprenols isolated from the green verdure of Picea abies (L.) Karst. This Biotechnology Company, Melbourne, Victoria, Australia study aimed to investigate effects of polyprenols on oligodendrogenesis, neurogenesis, 3 Department of Radiology, University of and myelin content in the cuprizone demyelination model. Demyelination was induced Washington, Seattle, WA, USA by 0.5% cuprizone in CD‐1 mice during 10 weeks. Nine cuprizone‐treated animals Correspondence received daily injections of polyprenols intraperitoneally at a dose of 12‐mg/kg body Marina Y. Khodanovich, Laboratory of weight during Weeks 6–10. Nine control animals and other nine cuprizone‐treated Neurobiology, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russian received sham oil injections. At Week 10, brain sections were stained for myelin basic Federation. protein, neuro‐glial antigen‐2, and doublecortin to evaluate demyelination, Email: [email protected] oligodendrogenesis, and neurogenesis. Cuprizone administration caused a decrease Funding information in myelin basic protein in the corpus callosum, cortex, hippocampus, and the caudate Ministry of Education and Science of the Russian Federation, Grant/Award Number: putamen compared with the controls.
    [Show full text]
  • ASHS Is Inviting/Encouraging Poster Presenters to Up- Posters: Load a PDF of Their Poster
    vt- •• ��t E�. Gallo Winery � BalL American Funding Generations of Floral Progress Through Research Image Analysis for Plant Science Endowment and Scholarships 1 of 262 General Information Conference Facilities: Speaker Ready Room: All Conference activities will take place at the Tropicana Oral, Workshop, Special Sessions, and Keynote speakers Las Vegas. are requested to check in at the Speaker Ready Room located in Churchill. Please note, even if you have Registration hours: uploaded in advance, you are still asked to check in at the Speaker Ready room at least 24 hours in advance of Sunday, July 21. .3:00 PM – 6:00 PM your presentation to confirm that your media and Pow- erPoint presentations were successfully uploaded and Monday, July 22 .............7:30 AM – 6:00 PM running properly. Updates and modifications can only Tuesday, July 23. 7:30 AM – 6:00 PM be made up to 24 hours in advance of your presentation. Wednesday, July 24. .7:30 AM – 5:00 PM Thursday, July 25 ............7:30 AM – 2:00 PM Poster Presenters and E-Posters: ASHS is inviting/encouraging poster presenters to up- Posters: load a PDF of their poster. You may also upload mp4 video or audio files to go along with the poster. Posters are located in Cohiba 5-12. As part of enhancing the ASHS online conference proceedings, you have the option to make your poster Poster Set Up: into an interactive electronic version (E-Poster). If you would like to explore this option, a link will appear once Monday, July 22 .............2:00 PM – 5:00 PM you have uploaded your PDF file with instructions on how to create your E-Poster.
    [Show full text]
  • Identification of Abies Sibirica L. Polyprenols and Characterisation Of
    molecules Article Identification of Abies sibirica L. Polyprenols and Characterisation of Polyprenol-Containing Liposomes Ilona Vanaga 1,2,3,*, Jerzy Gubernator 4, Ilva Nakurte 5,6 , Ugis Kletnieks 2,3, Ruta Muceniece 1 and Baiba Jansone 1 1 Department of Pharmacology, Faculty of Medicine, University of Latvia, Jelgavas str. 3, LV-1004 Riga, Latvia; [email protected] (R.M.); [email protected] (B.J.) 2 LTD “Silv EXPO”, Alberta str. 12-2, LV-1010 Riga, Latvia; [email protected] 3 JSC “Biolat”, Rigas str. 111, LV-2169 Salaspils, Latvia 4 Faculty of Biotechnology, University of Wroclaw, Joliot Currie 14A, 51-383 Wrocław, Poland; [email protected] 5 Institute for Environmental Solutions, „Lidlauks”, Priekulu parish, LV- 4101 Priekulu county, Latvia; [email protected] 6 Department of Physical Chemistry, Faculty of Chemistry, University of Latvia, Jelgavas str. 1, LV-1004 Riga, Latvia * Correspondence: [email protected]; Tel.: +371-29554716 Received: 21 February 2020; Accepted: 8 April 2020; Published: 14 April 2020 Abstract: The needles of conifer trees are one of the richest sources of natural polyprenols. Polyprenol homologs from Abies sibirica L. lipophilic 80% purified extract were analyzed and quantified. In total, 10 peaks (Prenol-11 to Prenol-20) were observed in the ultra-high-performance liquid chromatography–diode array detector (UHPLC-DAD) chromatogram of Siberian fir with the most abundant compound being Prenol-15 (relative amount 37.23 + 0.56% of the total polyprenol yield). Abies sibirica L. polyprenol solubility and incorporation efficiency into liposomes were studied in various commercially available lecithin mixtures (Phosal IP40, Phosal 75SA, and Lipoid P45).
    [Show full text]
  • Appendix 3 Review of Selected Papers and Discussion of the Research And
    Appendix 3 Review of selected papers and discussion of the research and other achievements Liliana Surmacz, PhD Institute of Biochemistry and Biophysics Polish Academy of Sciences Department of Lipid Biochemistry Pawińskiego 5a 02-106 Warsaw, Poland Warsaw 2017 Appendix 3 L. Surmacz 1. Name and surname: Liliana Surmacz 2. Diplomas, scientific degrees held - including the name, place and year of acquisition and the title of the doctoral dissertation: 2004 Ph.D. in Biology - Molecular Biology, Nencki Institute of Experimental Biology PAS in Warsaw, The title of Ph.D. thesis „Rab7 in Paramecium cells: studies on gene, protein and localization during endocytosis”, Supervisor: Prof. Elżbieta Wyroba 1995 M.Sc. in Biology - Microbiology, University of Lodz, Faculty of Biology and Earth Sciences, The title of M.Sc. thesis: „The use of an enzyme immunoassay APAAP for the identification of markers that differentiate human lymphocytes”, Supervisor: Prof. Wiesława Rudnicka 3. Information on employment in scientific institutions: science 10. 2006 till present Assistant Professor at the Department of Lipid Biochemistry, Institute of Biochemistry and Biophysics PAS, Warsaw, Poland. 09.2008 – 05.2010 maternity leave 09.2006 – 10.2006 biologist at the Department of Lipid Biochemistry, Institute of Biochemistry and Biophysics PAS, Warsaw, Poland. 12.1995 – 08.2006 assistant at the Laboratory of Cell Membrane Physiology, the Nencki Institute of Experimental Biology PAS, Warsaw, Poland 01.1998 – 01.2000 maternity leave 4. Description of the achievement under the Article 16.2 of the Act of 14 March 2003 on academic degrees and academic title and degrees and title in art (Journal of Laws, item 882, 2016 and item 1311, 2016): a) title of the scientific achievement, The scientific achievement consists of five papers published in the journals listed by the Journal Citation Report, total IF matching the year of publication is: 26.581 (WoS); total points (according to the list of the Ministry of Science and Higher Education, MSHE): 180; times cited: 58 (WoS).
    [Show full text]
  • REVIEW 5A-Reduced Glucocorticoids: a Story of Natural Selection
    111 REVIEW 5a-Reduced glucocorticoids: a story of natural selection Mark Nixon, Rita Upreti and Ruth Andrew Endocrinology, Queen’s Medical Research Institute, University/British Heart Foundation Centre for Cardiovascular Science, Edinburgh EH16 4TJ, UK (Correspondence should be addressed to R Andrew; Email: [email protected]) Abstract 5a-Reduced glucocorticoids (GCs) are formed when one of recently the abilities of 5a-reduced GCs to suppress the two isozymes of 5a-reductase reduces the D4–5 double inflammation have been demonstrated in vitro and in vivo. bond in the A-ring of GCs. These steroids are largely viewed Thus, the balance of parent GC and its 5a-reduced inert, despite the acceptance that other 5a-dihydro steroids, metabolite may critically affect the profile of GR signalling. e.g. 5a-dihydrotestosterone, retain or have increased activity 5a-Reduction of GCs is up-regulated in liver in metabolic at their cognate receptors. However, recent findings suggest disease and may represent a pathway that protects from both that 5a-reduced metabolites of corticosterone have dis- GC-induced fuel dyshomeostasis and concomitant inflam- sociated actions on GC receptors (GRs) in vivo and in vitro matory insult. Therefore, 5a-reduced steroids provide hope and are thus potential candidates for safer anti-inflammatory for drug development, but may also act as biomarkers of the steroids. 5a-Dihydro- and 5a-tetrahydro-corticosterone can inflammatory status of the liver in metabolic disease. With bind with GRs, but interest in these compounds had been these proposals in mind, careful attention must be paid to the limited, since they only weakly activated metabolic gene possible adverse metabolic effects of 5a-reductase inhibitors, transcription.
    [Show full text]
  • Streptomyces Coelicolor Strains Lacking Polyprenol Phosphate Mannose Synthase and Protein O-Mannosyl Transferase Are Hyper-Susceptible to Multiple Antibiotics
    This is a repository copy of Streptomyces coelicolor strains lacking polyprenol phosphate mannose synthase and protein O-mannosyl transferase are hyper-susceptible to multiple antibiotics. White Rose Research Online URL for this paper: https://eprints.whiterose.ac.uk/128020/ Version: Accepted Version Article: Howlett, Robert, Read, Nicholas, Varghese, Anpu S. et al. (3 more authors) (2018) Streptomyces coelicolor strains lacking polyprenol phosphate mannose synthase and protein O-mannosyl transferase are hyper-susceptible to multiple antibiotics. Microbiology. pp. 369-382. ISSN 1465-2080 https://doi.org/10.1099/mic.0.000605 Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Microb iology Streptomyces coelicolor strains lacking polyprenol phosphate mannose synthase and protein O-mannosyl transferase are hyper-susceptible to multiple antibiotics --Manuscript Draft-- Manuscript
    [Show full text]